Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance
Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance
复制标题
肥胖中 MicroRNA-592 的下调导致高血糖和胰岛素抵抗
DOI:
10.1016/j.ebiom.2019.03.041
复制
发表时间:
2019-04-01
期刊:
影响因子:
11.1
通讯作者:
Li, Yao
中科院分区:
文献类型:
--
作者:
Song, Yuping;Wu, Ling;Li, Yao
Background: Many studies have demonstrated that microRNAs, a class of small and non-coding RNA molecules, play an important role in the regulation of glucose and lipid homeostasis. In the present study, we sought to investigate the function of miR-592 in the development of obesity-associated metabolic disorders, including hyperglycemia andinsulin resistance.Methods: The expression levels ofmiR-592 were measured in the liver of obese mice and humans by quantitative reverse transcription PCR. Loss-and gain-of function experiments were employed to explore the metabolic function of miR-592 using locked nucleic acids and adenovirus in lean and obese mice, respectively. The molecular target of miR-592 was determined by western blotting and luciferase reporter assays.Findings: We found a significant decreased expression of miR-592 in the liver of obese mice and humans. Inhibition of miR-592 led to elevated blood glucose levels, enhanced gluconeogenesis and reduced insulin sensitivity in lean mice. In contrast, adenovirus-mediated overexpression of hepatic miR-592 improved metabolic disorders in obese mice. Mechanistically, we found that the transcription factor forkhead box O1 (FOXO1) is a direct target gene of miR-592 to mediate its metabolic functions. miR-592 was able to inhibit the mRNA and protein expression of FOXO1 by binding to its 3'-untranslated region.Interpretations: Our findings demonstrate that obesity-associated down-regulation of miR-592 plays an important role in the progression of metabolic diseases. Restoration of hepatic miR-592 could improve glucose and lipid metabolism in obese mice. (C) 2019 Published by Elsevier B.V.